Humana Inc. (NYSE:HUM) Shares Acquired by Tealwood Asset Management Inc.

Tealwood Asset Management Inc. lifted its position in Humana Inc. (NYSE:HUM) by 1.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,276 shares of the insurance provider’s stock after buying an additional 76 shares during the quarter. Tealwood Asset Management Inc.’s holdings in Humana were worth $1,354,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Pzena Investment Management LLC increased its position in shares of Humana by 538.7% during the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after acquiring an additional 1,955,375 shares during the period. Davis Selected Advisers grew its stake in Humana by 16.1% during the 2nd quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider’s stock worth $863,640,000 after purchasing an additional 321,233 shares in the last quarter. Marshall Wace LLP increased its holdings in Humana by 118.9% during the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after purchasing an additional 774,085 shares during the period. Legal & General Group Plc increased its holdings in Humana by 2.1% during the 2nd quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider’s stock worth $442,396,000 after purchasing an additional 24,842 shares during the period. Finally, Ontario Teachers Pension Plan Board boosted its stake in shares of Humana by 11,647.2% in the 1st quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after buying an additional 1,050,459 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on HUM. Cantor Fitzgerald restated a “neutral” rating and set a $395.00 target price on shares of Humana in a research note on Tuesday, October 1st. Piper Sandler lowered shares of Humana from an “overweight” rating to a “neutral” rating and reduced their price objective for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. Leerink Partnrs cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Leerink Partners lowered Humana from an “outperform” rating to a “market perform” rating and dropped their target price for the company from $400.00 to $250.00 in a report on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. lifted their price target on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. One analyst has rated the stock with a sell rating, eighteen have issued a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $324.86.

Humana Price Performance

Shares of HUM traded up $7.09 during trading hours on Tuesday, reaching $243.38. The company had a trading volume of 1,271,954 shares, compared to its average volume of 1,785,446. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $530.54. The firm has a 50 day simple moving average of $334.58 and a 200-day simple moving average of $342.37. The company has a market capitalization of $29.33 billion, a price-to-earnings ratio of 15.22, a PEG ratio of 2.44 and a beta of 0.50.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. Humana’s revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $8.94 earnings per share. Research analysts expect that Humana Inc. will post 16.01 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.45%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s payout ratio is 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.